These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 15327972)

  • 1. Improved antiviral activity of the aryloxymethoxyalaninyl phosphoramidate (APA) prodrug of abacavir (ABC) is due to the formation of markedly increased carbovir 5'-triphosphate metabolite levels.
    Balzarini J; Aquaro S; Hassan-Abdallah A; Daluge SM; Perno CF; McGuigan C
    FEBS Lett; 2004 Aug; 573(1-3):38-44. PubMed ID: 15327972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique intracellular activation of the potent anti-human immunodeficiency virus agent 1592U89.
    Faletto MB; Miller WH; Garvey EP; St Clair MH; Daluge SM; Good SS
    Antimicrob Agents Chemother; 1997 May; 41(5):1099-107. PubMed ID: 9145876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral activity of cyclosaligenyl prodrugs of acyclovir, carbovir and abacavir.
    Balzarini J; Haller-Meier F; De Clercq E; Meier C
    Antivir Chem Chemother; 2001 Sep; 12(5):301-6. PubMed ID: 11900349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of phosphoramidate pronucleotide technology to abacavir leads to a significant enhancement of antiviral potency.
    McGuigan C; Harris SA; Daluge SM; Gudmundsson KS; McLean EW; Burnette TC; Marr H; Hazen R; Condreay LD; Johnson L; De Clercq E; Balzarini J
    J Med Chem; 2005 May; 48(10):3504-15. PubMed ID: 15887959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steady-state pharmacokinetics of abacavir in plasma and intracellular carbovir triphosphate following administration of abacavir at 600 milligrams once daily and 300 milligrams twice daily in human immunodeficiency virus-infected subjects.
    Moyle G; Boffito M; Fletcher C; Higgs C; Hay PE; Song IH; Lou Y; Yuen GJ; Min SS; Guerini EM
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1532-8. PubMed ID: 19188387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane permeation characteristics of abacavir in human erythrocytes and human T-lymphoblastoid CD4+ CEM cells: comparison with (-)-carbovir.
    Mahony WB; Domin BA; Daluge SM; Zimmerman TP
    Biochem Pharmacol; 2004 Nov; 68(9):1797-805. PubMed ID: 15450945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing the mechanism of action and decomposition of amino acid phosphomonoester amidates of antiviral nucleoside prodrugs.
    McIntee EJ; Remmel RP; Schinazi RF; Abraham TW; Wagner CR
    J Med Chem; 1997 Oct; 40(21):3323-31. PubMed ID: 9341906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and anti-HIV activity of phosphoramidate derivatives of D4T-MP with variations in the amino acid moiety.
    Naesens L; Cahard D; Salgado A; Bidois L; De Clercq E; McGuigan C; Balzarini J
    Adv Exp Med Biol; 1998; 431():753-7. PubMed ID: 9598164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity.
    Daluge SM; Good SS; Faletto MB; Miller WH; St Clair MH; Boone LR; Tisdale M; Parry NR; Reardon JE; Dornsife RE; Averett DR; Krenitsky TA
    Antimicrob Agents Chemother; 1997 May; 41(5):1082-93. PubMed ID: 9145874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxy fatty acids for the delivery of dideoxynucleosides as anti-HIV agents.
    Gangadhara KL; Lescrinier E; Pannecouque C; Herdewijn P
    Bioorg Med Chem Lett; 2014 Feb; 24(3):817-20. PubMed ID: 24411122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and Antiviral Evaluation of TriPPPro-AbacavirTP, TriPPPro-CarbovirTP, and Their 1',2'-cis-Disubstituted Analogues.
    Weising S; Sterrenberg V; Schols D; Meier C
    ChemMedChem; 2018 Sep; 13(17):1771-1778. PubMed ID: 29943432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abacavir prodrugs: microwave-assisted synthesis and their evaluation of anti-HIV activities.
    Sriram D; Yogeeswari P; Myneedu NS; Saraswat V
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2127-9. PubMed ID: 16458506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syntheses and anti-HIV activities of (+/-)-norcarbovir and (+/-)-norabacavir.
    Huang W; Miller MJ; De Clercq E; Balzarini J
    Org Biomol Chem; 2007 Apr; 5(8):1164-6. PubMed ID: 17406712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A step further in the SATE mononucleotide prodrug approach.
    Peyrottes S; Villard AL; Coussot G; Augustijns P; Lefebvre I; Aubertin AM; Gosselin G; Périgaud C
    Nucleic Acids Symp Ser (Oxf); 2008; (52):539-40. PubMed ID: 18776492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prodrugs of HIV protease inhibitors-saquinavir, indinavir and nelfinavir-derived from diglycerides or amino acids: synthesis, stability and anti-HIV activity.
    Gaucher B; Rouquayrol M; Roche D; Greiner J; Aubertin AM; Vierling P
    Org Biomol Chem; 2004 Feb; 2(3):345-57. PubMed ID: 14747863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tools for eradicating HIV in the brain: prodrug dimeric inhibitors of P-gp.
    Chmielewski J; Hrycyna C
    Ther Deliv; 2012 Jun; 3(6):689-92. PubMed ID: 22838065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the activation pathway of phosphoramidate triester prodrugs of stavudine and zidovudine.
    Saboulard D; Naesens L; Cahard D; Salgado A; Pathirana R; Velazquez S; McGuigan C; De Clercq E; Balzarini J
    Mol Pharmacol; 1999 Oct; 56(4):693-704. PubMed ID: 10496951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of carbovir, a potent inhibitor of human immunodeficiency virus type 1, and its effects on cellular metabolism.
    Parker WB; Shaddix SC; Bowdon BJ; Rose LM; Vince R; Shannon WM; Bennett LL
    Antimicrob Agents Chemother; 1993 May; 37(5):1004-9. PubMed ID: 7685993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of a long-acting nanoformulated abacavir prodrug.
    Singh D; McMillan J; Hilaire J; Gautam N; Palandri D; Alnouti Y; Gendelman HE; Edagwa B
    Nanomedicine (Lond); 2016 Aug; 11(15):1913-27. PubMed ID: 27456759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretrovirus specificity and intracellular metabolism of 2',3' -didehydro-2',3'-dideoxythymidine (stavudine) and its 5'-monophosphate triester prodrug So324.
    Balzarini J; Egberink H; Hartmann K; Cahard D; Vahlenkamp T; Thormar H; De Clercq E; McGuigan C
    Mol Pharmacol; 1996 Nov; 50(5):1207-13. PubMed ID: 8913352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.